The length of the staphylococcus aureus protein a polymorphic region regulates inflammation: Impact on acute and chronic infection

Journal of Infectious Diseases

Volumn 206, Issue 1, 2012, Pages 81-90

  Garofalo, Ailin ^a   Giai, Constanza ^a   Lattar, Santiago ^a   Gardella, Noella ^a   Mollerach, Marta ^a,b   Kahl, Barbara C ^c   Becker, Karsten ^c   Prince, Alice S ^d   Sordelli, Daniel O ^a,b   Gómez, Marisa I ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; STAPHYLOCOCCUS PROTEIN A;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE DURATION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFECTION; INFLAMMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; SIMPLE SEQUENCE REPEAT; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; ANIMALS; CELL LINE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INFANT; INFLAMMATION; INTERFERON-BETA; MICE; MICE, INBRED BALB C; MICROSATELLITE REPEATS; NEUTROPHIL INFILTRATION; OSTEOMYELITIS; POLYMORPHISM, GENETIC; RESPIRATORY MUCOSA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84861565996     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis311     Document Type: Article

References (50)

1. Wos-Oxley ML, Plumeier I, von Eiff C, et al. A poke into the diversity and associations within human anterior nare microbial communities. ISME J 2010; 4:839-51.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
3. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
4. Tokumoto MB, Ybarra V, Torreno M, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) paediatric clone among skin and soft-tissue infections in Buenos Aires. Int J Antimicrob Agents 2007; 30:469-71.
5. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-6.
6. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3:948-58.
7. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-3.
8. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for communityassociated MRSA. Nat Med 2007; 13:1510-4.
9. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37:3556-63.
10. Langone JJ. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol 1982; 32:157-252.
11. Hartleib J, Kohler N, Dickinson RB, et al. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 2000; 96:2149-56.
12. Graille M, Stura EA, Corper AL, et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000; 97:5399-404.
13. Gomez MI, Lee A, Reddy B, et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 2004; 10:842-8.
14. Martin FJ, Gomez MI, Wetzel DM, et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 2009; 119:1931-9.
15. Kahl BC, Mellmann A, Deiwick S, Peters G, Harmsen D. Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus. J Clin Microbiol 2005; 43:502-5.
16. Frenay HM, Theelen JP, Schouls LM, et al. Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism. J Clin Microbiol 1994; 32:846-7.
17. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 2006; 281:20190-6.
18. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 2002; 4:759-70.
19. Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol 2007; 571:231-9.
20. National Institutes of Health. Guide for the care and use of laboratory animals. Washington, DC: National Research Council Guide, 1996.
21. Gardella N, Murzicato S, Di Gregorio S, et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina. Infect Genet Evol 2011; 11:1066-71.
22. Gardella N, von Specht M, Cuirolo A, Rosato A, Gutkind G, Mollerach M. Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina. Diagn Microbiol Infect Dis 2008; 62:343-7.
23. Lattar SM, Tuchscherr LPN, Centrón D, et al. Molecular fingerprinting of Staphylococcus aureus isolated from patients with osteomyelitis in Argentina and clonal distribution of the cap5(8)genes and of other selected virulence genes. Eur J Clin Microbiol Infect Dis 2012;E-published ahead of print March 23.
24. Rolauffs B, Bernhardt TM, von Eiff C, Hart ML, Bettin D. Osteopetrosis, femoral fracture, and chronic osteomyelitis caused by Staphylococcus aureus small colony variants (SCV) treated by girdlestone resection-6-year follow-up. Arch Orthop Trauma Surg 2002; 122:547-50.
25. Kahl BC, Duebbers A, Lubritz G, et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol 2003; 41:4424-7.
26. Kelly-Scumpia KM, Scumpia PO, Delano MJ, et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med 2010; 207:319-26.
27. Punturieri A, Alviani RS, Polak T, Copper P, Sonstein J, Curtis JL. Specific engagement of TLR4 or TLR3 does not lead to IFN-betamediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol 2004; 173:1033-42.
28. Gomez MI, Sokol SH, Muir AB, Soong G, Bastien J, Prince AS. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol 2005; 175:1930-6.
29. Fowler VG Jr, Nelson CL, McIntyre LM, et al. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 2007; 196:738-47.
30. Frenay HM, Bunschoten AE, Schouls LM, et al. Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996; 15:60-4.
31. Ghebremedhin B, Konig W, Witte W, Hardy KJ, Hawkey PM, Konig B. Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol 2007; 56:365-75.
32. Strommenger B, Braulke C, Pasemann B, Schmidt C, Witte W. Multiplex PCR for rapid detection of Staphylococcus aureus isolates suspected to represent community-acquired strains. J Clin Microbiol 2008; 46:582-7.
33. Kennedy AD, Otto M, Braughton KR, et al. Epidemic communityassociated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci USA 2008; 105:1327-32.
34. Donnio PY, Fevrier F, Bifani P, et al. Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitals. Antimicrob Agents Chemother 2007; 51:4342-50.
35. Sola C, Saka HA, Vindel A, Bocco JL. Emergence and dissemination of a community-associated methicillin-resistant Panton-Valentine leucocidin-positive Staphylococcus aureus clone sharing the sequence type 5 lineage with the most prevalent nosocomial clone in the same region of Argentina. J Clin Microbiol 2008; 46:1826-31.
36. Kurlenda J, Grinholc M, Szweda P. Lack of correlation between X region spa polymorphism and virulence of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Acta Biochim Pol 2010; 57:135-8.
37. Lowy FD. Secrets of a superbug. Nat Med 2007; 13:1418-20.
38. Mahieu T, Libert C. Should we inhibit type I interferons in sepsis? Infect Immun 2007; 75:22-9.
39. Mancuso G, Midiri A, Biondo C, et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 2007; 178:3126-33.
40. Parker D, Martin FJ, Soong G, et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2011; doi: 10.1128/mBio.00016-11.
41. Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, Prince A. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 2012, 46:6-13.
42. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119:1910-20.
43. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, Lowy FD. A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 2010; 201:508-15.
44. Goerke C, Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol 2010; 300:520-5.
45. Tuchscherr L, Loffler B, Buzzola FR, Sordelli DO. Staphylococcus aureus adaptation to the host and persistence: role of loss of capsular polysaccharide expression. Future Microbiol 2010; 5:1823-32.
46. Proctor RA, von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4:295-305.
47. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
48. Boye K, Westh H. Variations in spa types found in consecutive MRSA isolates from the same patients. FEMS Microbiol Lett 2011; 314:101-5.
49. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006; 12:17-25.
50. Gomez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007; 7:244-51.